Immunotherapy of Relapsed and Refractory Solid Tumors With Ex Vivo Expanded Multi-Tumor Associated Antigen Specific Cytotoxic T Lymphocytes: A Phase I Study.

Authors

Amy B Hont, George Washington University
C Russell Cruz, George Washington University
Robert Ulrey
Barbara O'Brien
Maja Stanojevic
Anushree Datar
Shuroug Albihani
Devin Saunders
Ryo Hanajiri
Karuna Panchapakesan
Sam Darko
Payal Banerjee
Maria Fernanda Fortiz
Fahmida Hoq
Haili Lang
Yunfei Wang
Patrick J Hanley, George Washington University
Jeffrey S Dome
Catherine M Bollard, George Washington University
Holly J Meany, George Washington University

Document Type

Journal Article

Publication Date

9-10-2019

Journal

Journal of Clinical Oncology : official journal of the American Society of Clinical Oncology

Volume

37

Issue

26

Inclusive Pages

2349-2359

DOI

10.1200/JCO.19.00177

Comments

Epub 2019 Jul 29

APA Citation

Hont, A., Cruz, C., Ulrey, R., O'Brien, B., Stanojevic, M., Datar, A., Albihani, S., Saunders, D., Hanajiri, R., Panchapakesan, K., Darko, S., Banerjee, P., Fortiz, M., Hoq, F., Lang, H., Wang, Y., Hanley, P., Dome, J., Bollard, C., & Meany, H. (2019). Immunotherapy of Relapsed and Refractory Solid Tumors With Ex Vivo Expanded Multi-Tumor Associated Antigen Specific Cytotoxic T Lymphocytes: A Phase I Study.. Journal of Clinical Oncology : official journal of the American Society of Clinical Oncology, 37 (26). http://dx.doi.org/10.1200/JCO.19.00177

Peer Reviewed

1